Furthermore, treatment with an anti-CD244 monoclonal antibody significantly impaired the growth of established HNSCC tumors in wild-type mice and increased the infiltration of CD8+ T cells within the tumors (Agresta et al., 2020). The gene discussed is CD244; the disease is head and neck squamous cell carcinoma.